Table 2 Semi-quantitative results of MRI evaluation for each muscle group in Pompe disease
From: 2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease
Muscle | T1w (Median) | T1w (IQRa) | STIR (Median) | STIR (IQRa) | T1 FS CE (Median) | T1 FS CE (IQRa) |
|---|---|---|---|---|---|---|
Intrinsic back muscles (lower back) | 3.0 | 3.0–3.0 | 0.0 | 0.0–3.0 | 0.0 | 0.0–3.0 |
Iliopsoas | 2.0 | 0.5–3.5 | 1.0 | 0.0–2.5 | 1.5 | 0.0–2.5 |
Gluteus maximus (lateral) | 2.0 | 0.5–4.0 | 1.0 | 0.0–2.0 | 1.5 | 0.5–2.0 |
Gluteus maximus (center) | 0.0 | 0.0–1.5 | 0.0 | 0.0–1.5 | 0.0 | 0.0–1.5 |
Gluteus maximus (medial) | 1.5 | 0.0–3.0 | 1.0 | 0.0–2.0 | 1.0 | 0.0–2.5 |
Gluteus medius (ventral) | 2.0 | 1.0–3.5 | 1.5 | 1.0–2.0 | 2.0 | 1.0–3.5 |
Gluteus medius (dorsal) | 3.5 | 1.5–4.0 | 1.0 | 0.0–1.5 | 0.5 | 0.0–1.5 |
Gluteus minimus (ventral) | 4.0 | 3.5–4.0 | 0.5 | 0.0–1.5 | 0.5 | 0.0–1.5 |
Gluteus minimus (dorsal) | 4.0 | 3.5–4.0 | 0.5 | 0.0–1.5 | 0.5 | 0.0–1.5 |
Rectus femoris | 0.0 | 0.0–0.0 | 0.0 | 0.0–0.0 | 0.0 | 0.0–0.0 |
Sartorius | 0.0 | 0.0–0.0 | 0.0 | 0.0–0.0 | 0.0 | 0.0–0.0 |
Obturator ext. | 1.0 | 0.5–2.0 | 0.0 | 0.0–0.5 | 0.0 | 0.0–0.5 |
Pectineus | 0.0 | 0.0–2.5 | 0.0 | 0.0–0.0 | 0.0 | 0.0–0.0 |